Skip to main content

JPMORGAN CHASE & CO

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 19617 NEW YORK, NY

Position in TSHA

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$3,373,873
-$885,393 QoQ
Shares Held
754,782
-2.5% QoQ
Ownership
0.263%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 62.73546533966099.ToString("F0")% Shared 0.ToString("F0")% None 37.26453466033901.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. TSHA ranks #120 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,373,873 754,782
2025-12-31 $4,259,266 774,412
2025-09-30 $968,717 296,244
2025-06-30 $514,318 222,649
2025-03-31 $1,394,261 1,003,067
2024-12-31 $4,573,694 2,643,755
2024-09-30 $6,032,807 3,001,397
2024-06-30 $6,638,356 2,963,553
2024-03-31 $269,036 93,741
2023-12-31 $64,576 36,484
2023-09-30 $432 137
2023-06-30 $1,177 1,782
2023-03-31 $1,422 1,782
2022-12-31 $4,027 1,782
2022-09-30 $85,996 44,558
2022-06-30 $1,038,962 279,291
2022-03-31 $2,867,520 439,804
2021-12-31 $2,767,560 237,559
2021-09-30 $7,827,138 420,362
2021-06-30 $4,529,293 213,646
2021-03-31 $532,325 26,223
2020-12-31 $630,271 23,748